Back to HALO
AlphaCentric Advisors LLC → HALO
AlphaCentric Advisors LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$1.1M
Q3 2026
Peak value
$1.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $305K |
| Q1 2026 | $310K |
| Q2 2026 | $738K |
| Q3 2026 | $1.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.1M | 9.8K | — | — |
| Q2 2026 | $738K | 9.4K | — | — |
| Q1 2026 | $310K | 4.8K | — | — |
| Q4 2025 | $305K | 4.5K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M